Millennium Management’s AYTU BioPharma AYTU Stock Holding History

Millennium Management’s Portfolio AYTU Stock Details AYTU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-10,369	Closed	-$17.3K	–	5848
2024 Q4	$17.3K	Buy	+10,369	New	+$18.9K	﹤0.01%	5726
2023 Q1	–	Sell	-59,498	Closed	-$225K	–	6356
2022 Q4	$225K	Buy	59,498 +39,006	+190%	+$147K	﹤0.01%	5261
2022 Q3	$76K	Buy	20,492 +11,752	+134%	+$89.2K	﹤0.01%	6056
2022 Q2	$121K	Sell	8,740 -4,556	-34%	-$58.3K	﹤0.01%	5863
2022 Q1	$287K	Sell	13,296 -1,493	-10%	-$37.1K	﹤0.01%	5586
2021 Q4	$399K	Sell	14,789 -3,224	-18%	-$139K	﹤0.01%	5258
2021 Q3	$1.04M	Sell	18,013 -4,008	-18%	-$301K	﹤0.01%	4637
2021 Q2	$2.21M	Buy	+22,021	New	+$2.58M	﹤0.01%	3846
2020 Q3	–	Sell	-299	Closed	-$85K	–	4433
2020 Q2	$85K	Buy	299 +173	+137%	+$52.4K	﹤0.01%	3998
2020 Q1	$38K	Buy	+126	New	+$24.3K	﹤0.01%	3689

Other funds holding AYTU

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JIP

Jaffetilchin Investment Partners Tampa, Florida $1.68B AUM 22.81% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Millennium Management's AYTU Position: Q1 2025 in Review

Millennium Management sold out of AYTU BioPharma (AYTU) in Q1 2025, closing a stake of 10,369 shares — an estimated $17.3K sold.

Millennium Management first reported a position in AYTU in Q1 2020 and held it in 10 quarters. The position peaked at $2.21M in Q2 2021. 31 funds tracked by Wall St. Rank hold AYTU as of Q1 2025.

Millennium Management reported no remaining AYTU BioPharma position as of Q1 2025 after selling out during the quarter.
Millennium Management sold 10,369 AYTU BioPharma shares in Q1 2025, an estimated $17.3K.
Millennium Management first reported a position in AYTU BioPharma in Q1 2020 and held it in 10 quarters.
Millennium Management's AYTU BioPharma position peaked at $2.21M in Q2 2021.
31 funds tracked by Wall St. Rank held AYTU BioPharma as of Q1 2025.

Based on Millennium Management's 13F filing for Q1 2025, filed 15 May 2025.